Xvivo Perfusion AB (publ) is a specialized medtech company creating advanced technologies for the preservation and perfusion of organs, tissues, and cells, vital for successful transplantation. Founded in 1998 and headquartered in Gothenburg, Sweden, the company extends its operations across Sweden, the United States, the broader regions of North and South America, Europe, the Middle East, Africa, and the Asia Pacific. Their product line encompasses the XVIVO System (XPS), an integrated, off-the-shelf cardiac bypass system engineered for secure normothermic ex vivo lung perfusion (EVLP). Accompanying this is the XPS Disposable Lung Kit, supplying necessary sterile disposables and pre-packaged components. They also provide STEEN Solution, a uniquely formulated buffered extracellular solution optimized for perfusing isolated donor lungs during EVLP, and Perfadex Plus, an extracellular, low-potassium, dextran-based electrolyte solution for organ preservation. Additional offerings include the XVIVO Silicone Tubing Set for efficient flushing of donor lungs during procurement, as well as the XVIVO LS and XVIVO Disposable Lung Set, which together constitute a dedicated EVLP device. Furthermore, Xvivo Perfusion supplies the XVIVO Organ Chamber, a single-use sterile disposable container designed as a temporary holding unit for isolated lungs before transplantation, alongside the single-use, sterile XVIVO Lung Cannula Set.
The current price of XVIPY is $5.27 USD — it has increased by +0% in the past 24 hours. Watch Xvivo Perfusion AB stock price performance more closely on the chart.
What is Xvivo Perfusion AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Xvivo Perfusion AB stocks are traded under the ticker XVIPY.
Is Xvivo Perfusion AB stock price growing?▼
XVIPY stock has fallen by -4.27% compared to the previous week, the month change is a -4.27% fall, over the last year Xvivo Perfusion AB has showed a +7.45% increase.
What is Xvivo Perfusion AB market cap?▼
Today Xvivo Perfusion AB has the market capitalization of 165.84M
When is the next Xvivo Perfusion AB earnings date?▼
Xvivo Perfusion AB is going to release the next earnings report on January 28, 2027.
What were Xvivo Perfusion AB earnings last quarter?▼
XVIPY earnings for the last quarter are 0.14 USD per share, whereas the estimation was 0.06 USD resulting in a +116.6% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Xvivo Perfusion AB revenue for the last year?▼
Xvivo Perfusion AB revenue for the last year amounts to 85.26M USD.
What is Xvivo Perfusion AB net income for the last year?▼
XVIPY net income for the last year is 2.82M USD.
How many employees does Xvivo Perfusion AB have?▼
As of November 7, 2026, the company has 210 employees.
In which sector is Xvivo Perfusion AB located?▼
Xvivo Perfusion AB operates in the Health & Wellness sector.
When did Xvivo Perfusion AB complete a stock split?▼
Xvivo Perfusion AB has not had any recent stock splits.
Where is Xvivo Perfusion AB headquartered?▼
Xvivo Perfusion AB is headquartered in Mölndal, Sweden.